Elsa Anes Selected Research

Elsa Anes Research Topics

Disease

20	Tuberculosis (Tuberculoses) 02/2024 - 10/2008
17	Infections 02/2024 - 08/2008
4	HIV Infections (HIV Infection) 03/2023 - 01/2021
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 02/2024 - 01/2022
2	Extensively Drug-Resistant Tuberculosis 07/2023 - 09/2022
2	Coinfection 01/2021 - 01/2021
1	Disease Progression 03/2023
1	Wounds and Injuries (Trauma) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Neoplasms (Cancer) 01/2022
1	COVID-19 10/2021
1	Persistent Infection 01/2021
1	Necrosis 01/2017
1	Communicable Diseases (Infectious Diseases) 03/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Ulcerative Colitis 09/2007

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 07/2023 - 01/2021
5	CathepsinsIBA 01/2023 - 08/2008
4	EnzymesIBA 04/2023 - 08/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2013
2	Carbapenems (Carbapenem Antibiotics)IBA 02/2024 - 01/2022
2	beta-LactamsIBA 02/2024 - 01/2022
2	CystatinsIBA 07/2023 - 01/2021
2	Cystatin CIBA 04/2023 - 01/2021
2	Saquinavir (Invirase)FDA Link 01/2023 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2010
1	CytokinesIBA 02/2024
1	A-factor (Streptomyces)IBA 03/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	FluoroquinolonesIBA 09/2022
1	Antitubercular AgentsIBA 09/2022
1	ProdrugsIBA 09/2022
1	Benzoic Acid (Potassium Benzoate)FDA Link 09/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	cathepsin SIBA 01/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2016
1	Thioridazine (Mellaril)FDA LinkGeneric 01/2016
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2016
1	Ion Channels (Ion Channel)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	pyrazinamide deamidaseIBA 12/2015
1	pyrazinoic acidIBA 12/2015
1	NLR ProteinsIBA 08/2010
1	InflammasomesIBA 08/2010
1	Inflammation MediatorsIBA 08/2010
1	Virulence Factors (Pathogenicity Factors)IBA 08/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 08/2010
1	Small Interfering RNA (siRNA)IBA 08/2010
1	sphingosine kinaseIBA 05/2010
1	Eicosapentaenoic AcidIBA 10/2008
1	Arachidonic Acid (Vitamin F)IBA 10/2008
1	LipidsIBA 10/2008
1	NF-kappa B (NF-kB)IBA 08/2008
1	Phosphatidylcholines (Phosphatidylcholine)IBA 09/2007

Therapy/Procedure

12	Therapeutics 02/2024 - 09/2007
2	Drug Therapy (Chemotherapy) 01/2016 - 04/2015
1	Art Therapy 03/2023